Antibody Theory Debunked
Source: Antibody Theory.
Also see:
Vaccinations Quotes
Disease Theory References
The Antibody Ruse And
False Science
Big business:
"The antibody business:
Millions of screening tests are distributed, each blood sample needs to be
tested (4 million in Germany alone) - The origins of BSE? by Mark Purdey.
The epidemic-like character of these diseases is generated by a molecular biological phenomenon, namely so-called test explosions. Today molecular biology is capable of detecting the smallest quantities of DNA or RNA with the PCR (Polymerase Chain Reaction) and able to produce antibodies against it. The connection between what has been isolated in humans or animals, and the presence of clinical symptoms, is a mere hypothesis. This is perfectly illustrated in BSE, where a testing epidemic has also taken place now, and still not one clinical symptom (a mad cow) has appeared [in Germany].
Because the symptoms are often missing, they must proclaim endless latency periods, up to 55 years (between infection with the "BSE pathogen" and developing the new variant of Creutzfeld-Jakob-Disease). See Myths & Truths About Beef and Mad Cow Disease is Caused by Mineral Imbalances.
Antibodies Used as A Measure of Immunity:
He said the normal trials on a new vaccine were not possible in Britain because of the relatively small numbers of people who contracted the disease. Instead scientists had tested whether the vaccine produced sufficient antibodies - Media Report on Meningitis C Vaccine.
The administration of Rabies Vaccine Inactivated (Diploid Cell Origin), Dried, stimulates the rapid development of specific antibodies - Rabies Vaccine Inactivated (Diploid Cell Origin), Dried.
Antibodies Not a Measure of Immunity:
The theory that the creation of
antibodies in the blood indicates that protection against disease has been
established is not supported by experience. The Medical Research Council's
Report on Diphtheria Outbreaks in Gateshead and Dundee, published in 1950 showed
that many of the persons actually in hospital with diphtheria had far more
anti-toxin in their blood than was said to be required for complete protection
against diphtheria, whilst nurses and others in close contact with diphtheria
infection and without sufficient anti-toxin remained immune - [1957] The Brains Of The Inoculated, Speech by Lily Loat.
"Human trials generally correlate
"antibody" responses with protection - that is if the body produces
antibodies (proteins) which bind to vaccine components, then
it must be working and safe. Yet Dr March says antibody response is generally a
poor measure of protection and no indicator at all of safety.
"Particularly for viral diseases, the 'cellular' immune response is all
important, and antibody levels and protection are totally unconnected - Private Eye 24/1/2002.
"The fallacy of this (antibody
theory) was exposed nearly 50 years ago, which is hardly recent. A report
published by the Medical Research Council entitled 'A study of diphtheria in
two areas of Gt. Britain,' Special report series 272, HMSO 1950 demonstrated
that many of the diphtheria patients had high levels of circulating antibodies,
whereas many of the contacts who remained perfectly well had low
antibody - Glen Dettman Ph.D Interview, by Jay Patrick, and quoted in "The Great American Deception," Let's Live, December 1976, p. 57.
"Many measles vaccine efficacy studies relate to their ability to stimulate an antibody response, (sero-conversion or sero-response). An antibody response does not necessarily equate to immunity.... the level
of antibody needed for effective immunity is different in each individual..... immunity can be demonstrated in individuals with a low or no detectable levels of antibody.
Similarly, in other individuals with higher levels of antibody there may be no immunity. We therefore need to stay clear on the issue: How do we know if the vaccine is effective for a particular individual when we do not know what level of antibody production equals immunity? - A Jab in the Dark
" The antibody business: Millions of screening tests are distributed, each blood sample needs to be tested (4 million in Germany alone) ... The therapy business: Antiviral medication, 3 or 4 or 5 fold combinations, AIDS can't be topped in this department. ....... With intoxication hypotheses on the other hand you cannot make any money at all. The simple message is: Avoid the poison and you won't get sick.
Such hypotheses are counterproductive insofar as the toxins (drugs, alcohol, pills, phosmet) bring high revenues. The conflict of interests is not resolvable: What virologist who does directly profit millions from their patent rights of the HIV or HCV tests (Montagnier, Simon Wain-Hobsen, Robin Weiss, Robert
Gallo) can risk to take even one look in the other direction - Meningitis by Dr Jayne Donegan.
"Whenever we read vaccine papers the MD researchers always assume that if there are high antibody levels after vaccination, then there is immunity (immunogencity). But are antibody levels and immunity the same? No! Antibody levels are not the same as IMMUNITY.
The recent MUMPS vaccine fiasco in Switzerland has re-emphasized this point. Three mumps vaccines-Rubini, Jeryl-Lynn and Urabe (the one was withdrawn because it caused encephalitis) all produced excellent antibody
levels but those vaccinated with the Rubini strain had the same attack rate as those not vaccinated at all; there were some who said that it actually caused outbreaks.
Reference: Schegal M et al Comparative efficacy of three mumps vaccines during disease outbreak in
Switzerland: cohort study. BMJ, 1999; 319:352-3."--Obomsawin, MD.
FROM REPEATED medical investigations, it would seem that antibodies are about as
useful as a black eye in protecting the victim from further attacks. The word "antibody" covers a number of even less intelligible words, quaint relics of Erlich's side-chain theory, which the greatest of experts, McDonagh, tells us is "essentially unintelligible". Now that the old history, mythology and statistics of vaccination have been exploded by experience, the business has to depend more upon verbal dust thrown in the face of the lay public.
The mere layman, assailed by antibodies, receptors, haptophores, etc., is only too pleased to give up the fight and leave everything to the experts. This is just what they want, especially when he is so pleased that he also leaves them lots and lots of real money.
The whole subject of immunity and antibodies is, however, so extremely complex and difficult, especially to the real experts, that it is a relief to be told that the gaps in their knowledge of such things are still enormous.
We can obtain some idea of the complexity of the subject from The Integrity of the Human Body, by Sir Macfarlane Burnet. He calls attention to the fact–the mystery–that some children can never develop
any antibodies at all, but can nevertheless go through a typical attack of, say, measles, make a normal recovery and show the normal continuing resistance to reinfection. Furthermore, we have heard for years past of attempts made to relate the amount of antibody in patients to their degree of immunity to infection.
The, results have often been so farcically chaotic, so entirely unlike what was expected, that the scandal has had to be hushed up–or put into a report, which is much the same thing: (M.R.C. Report, No. 272, May 1950, A Study of Diphtheria in Two Areas of Great Britain, now out of print). The worse scandal, however, is that the radio is still telling the schools that the purpose of vaccinating is to produce antibodies. The purpose of vaccinating is to make money! - Lionel Dole.
Crone, NE; Reder, AT; Severe tetanus in immunized patients with high anti-tetanus titers;
Neurology 1992; 42:761-764;
Article abstract: Severe (grade III) tetanus occurred in three immunized patients who had high serum levels of anti-tetanus antibody. The disease was fatal in one patient. One patient had been hyperimmunized to produce commercial tetanus immune globulin.
Two patients had received immunizations one year before presentation. Anti-tetanus antibody titers on admission were 25 IU/ml to 0.15 IU/ml by hemagglutination and ELISA assays; greater than 0.01 IU/ml is considered protective.
Even though one patient had seemingly adequate anti-tetanus titers by in vitro measurement 0.20 IU
in vivo mouse protection bioassays showed a titer less than 0.01 IU/ml, implying that there may have been a hole in her immune repertoire to tetanus neurotoxin but not to toxoid.
This is the first report of grade III tetanus with protective levels of antibody in the United States. The diagnosis of tetanus, nevertheless, should not be discarded solely on the basis of seemingly protective anti-tetanus titers.
Antibody titres are not equivalent to immunity. Studies show that antibody levels induced by vaccine are also
lower than those following natural infection (Weibel RE, Sokes J Jr, Buynak EB, Whitman JE Jr, Hilleman MR. Live, attenuated mumps-virusvaccine: 3. Clinical and serologic aspects in a field situation. N Engl J Med 1967;276:245-51 and Weibel RE, Buyak EB, McLean AA, Roehm RR, Hilleman MR. Follow-up surveillance for
antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines. ProcSoc Exp Biol Med 1979;162:328-32.)
Field studies show lower estimates for vaccine effectiveness than would be consistent with antibody titres, sometimes dramatically so (Chaiken BP, Williams NM, Preblud SR, Parkin W, Altman R. The effect of a
school entry law on mumps activity in a school district. JAMA 1987;257(18):2455-8 and Kim-Farley R, Bart S, Stetler H, et al. Clinical mumps vaccine efficacy. Am J Epidemiol 1985;121:593-7.)
|